4551 — Torii Pharmaceutical Co Share News
0.000.00%
Last trade - 00:00- ¥178bn
- ¥144bn
- ¥60bn
Table: Torii Pharmaceutical - Q1 parent results
Brief: Japan Tobacco - Resolved To Make Shareholder Proposal An Agenda Item For General Meeting Of Shareholders, Also Resolved To Oppose The Proposal
Opposes Plan Submitted By Activist Fund Lim Japan Event Master Fund
Table: Torii Pharmaceutical -2022 parent results
Has Entered Into A License Agreement With Nogra Pharma Limited To Develop & Commercialize Nac-Ged-0507 In Japan
Deals of the day-Mergers and acquisitions
Japan Tobacco urged to sell drug unit by activist shareholder LIM (updated)
Japan Tobacco urged to sell drug unit by activist shareholder LIM
Table: Torii Pharmaceutical - 9-MTH parent results
Table: Torii Pharmaceutical - 6-MTH parent results
Table: Torii Pharmaceutical - Q1 parent results
Table: Torii Pharmaceutical -2021 parent results
Brief: A Hong Kong-Based Activist Hedge Fund Is Pushing Torii Pharmaceuticals To Ban Accepting Execs From Parent Japan Tobacco - Nikkei
Table: Torii Pharmaceutical - 9-MTH parent results
Table: Torii Pharmaceutical - 6-MTH parent results
Investment Manager’s Year End Review
Table: Torii Pharmaceutical - Q1 parent results
BioCryst: Rises as genetic disorder drug to launch in Japan
Verrica Pharma: Up on license deal for lead skin disease treatment in Japan